prof. dr. Griet Glorieux

Journal Article
A1
open access

The omics-driven machine learning path to cost-effective precision medicine in chronic kidney disease

M Lopes, R Coletti, f Duranton, Griet Glorieux (UGent) , MA Jaimes Campos, Julie Klein, M Ley, P Perco, A Sampri and A Tur-Sinai

(2025) PROTEOMICS.

Add to list

Journal Article
A1
open access

Future of uremic toxin management

Raymond Vanholder (UGent) , Evelien Snauwaert (UGent) , Francis Verbeke (UGent) and Griet Glorieux (UGent)

(2024) TOXINS. 16(11).

Add to list

Journal Article
A1
open access

Assessment of within- and inter-patient variability of uremic toxin concentrations in children with CKD

Evelien Snauwaert (UGent) , Stefanie De Buyser (UGent) , An Desloovere (UGent) , Wim Van Biesen (UGent) , Ann Raes (UGent) , Griet Glorieux (UGent) , Laure Collard, Koen Van Hoeck, Maria Van Dyck, Nathalie Godefroid, et al.

(2024) TOXINS. 16(8).

Add to list

Journal Article
A2
open access

Integration of urinary peptidome and fecal microbiome to explore patient clustering in chronic kidney disease

Emmanouil Mavrogeorgis, Sophie Valkenburg (UGent) , Justyna Siwy, Agnieszka Latosinska, Griet Glorieux (UGent) , Harald Mischak and Joachim Jankowski

(2024) PROTEOMES. 12(2).

Add to list

Journal Article
A1
open access

Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD

Sonnal Lohia, Sophie Valkenburg (UGent) , Rafael Stroggilos, Vasiliki Lygirou, Manousos Makridakis, Jerome Zoidakis, Francis Verbeke (UGent) , Griet Glorieux (UGent) and Antonia Vlahou

(2024) HELIYON. 10(12).

Add to list

Journal Article
A1
open access

Revitalizing the gut microbiome in chronic kidney disease : a comprehensive exploration of the therapeutic potential of physical activity

Marieke Vandecruys, Stefan De Smet, Jasmine De Beir (UGent) , Marie Renier, Sofie Leunis, Hanne Van Criekinge, Griet Glorieux (UGent) , Jeroen Raes, Karsten Vanden Wyngaert (UGent) , Evi Nagler (UGent) , et al.

(2024) TOXINS. 16(6).

Add to list

Journal Article
A1
open access

Indoxyl sulfate contributes to impaired height velocity in (pre)school children

Evelien Snauwaert (UGent) , Stefanie De Buyser (UGent) , Wim Van Biesen (UGent) , Ann Raes (UGent) , Griet Glorieux (UGent) , Laure Collard, Koen Van Hoeck, Maria Van Dyck, Nathalie Godefroid, Johan Vande Walle (UGent) , et al.

(2024) KIDNEY INTERNATIONAL REPORTS. 9(6). p.1674-1683

Add to list

Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

Ana Amaya-Garrido, Manon Brunet, Benedicte Buffin-Meyer, Alexis Piedrafita, Lucile Grzesiak, Ezechiel Agbegbo, Arnaud Del Bello, Ines Ferrandiz, Serban Ardeleanu, Marcelino Bermudez-Lopez, et al.

(2023) SCIENCE TRANSLATIONAL MEDICINE. 15(712).

Add to list

Impact of symbiotics on uremic toxins production, renal function and PEW syndrome in SHIME and CKD mice models

Alice Beau, Berengere Benoit, Marie Jammes, Claudie Pinteur, Denis Fouque, Griet Glorieux (UGent) , Hubert Vidal, Jane Natividad and Laetitia Koppe

(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I419-I420

Add to list

Modulation of blood pressure through microbiome exchange between milan normotensive and hypertensive strains of rats

Yoko Suzumoto, Abbas Shams, Luciano D'apolito, Consiglia Longobardi, Francesco Trepiccione, Cristoforo Silvestri, Griet Glorieux (UGent) , Vincenzo Di Marzo and Giovambattista Capasso

(2023) NEPHROLOGY DIALYSIS TRANSPLANTATION. In Nephrology Dialysis Transplantation 38(Supplement 1). p.I975-I976

Academic Bibliography

prof. dr. Griet Glorieux

The omics-driven machine learning path to cost-effective precision medicine in chronic kidney disease

Future of uremic toxin management

Assessment of within- and inter-patient variability of uremic toxin concentrations in children with CKD

Integration of urinary peptidome and fecal microbiome to explore patient clustering in chronic kidney disease

Investigation of the human-gut-kidney axis by fecal proteomics, highlights molecular mechanisms affected in CKD

Revitalizing the gut microbiome in chronic kidney disease : a comprehensive exploration of the therapeutic potential of physical activity

Indoxyl sulfate contributes to impaired height velocity in (pre)school children

Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease

Impact of symbiotics on uremic toxins production, renal function and PEW syndrome in SHIME and CKD mice models

Modulation of blood pressure through microbiome exchange between milan normotensive and hypertensive strains of rats

Contents

Support

Contact